Syapse Stock
Syapse enable healthcare providers to deliver the best care to every cancer patient through precision medicine.
About Syapse Stock
Syapse works with health systems to implement precision medicine programs across their organizations, enabling oncologists to deliver personalized care to every patient who needs it.
Funding History
| January 2011 | $1.6M |
|---|---|
| January 2013 | $3.0M |
| July 2014 | $10.0M |
| January 2016 | $25.0M |
| November 2017 | $30.0M |
Management
SVP Product Development
James Lim
Chief Executive Officer
Ken Tarkoff
Founder and President
Jonathan Hirsch
Chief Technology Officer
Tony Loeser
Sr. Product Manager
David Leal
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Syapse or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
